Previous Article | Next Article 
Molecular and Cellular Biology, July 2003, p. 5056-5063, Vol. 23, No. 14
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.14.5056-5063.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability
Ellen E. McCarthy,1,2 Julide T. Celebi,2,3 Richard Baer,2,4 and Thomas Ludwig1,2*
Departments of Anatomy and Cell Biology,1
Dermatology,3
Pathology,4
Institute of Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York, New York 100322
Received 18 December 2002/
Returned for modification 18 February 2003/
Accepted 28 April 2003
The BRCA1 tumor suppressor has been implicated in many cellular pathways, but the mechanisms by which it suppresses tumor formation are not fully understood. In vivo BRCA1 forms a heterodimeric complex with the related BARD1 protein, and its enzymatic activity as a ubiquitin ligase is largely dependent upon its interaction with BARD1. To explore the genetic relationship between BRCA1 and BARD1, we have examined the phenotype of Bard1-null mice. These mice become developmentally retarded and die between embryonic day 7.5 (E7.5) and E8.5. Embryonic lethality results from a severe impairment of cell proliferation that is not accompanied by increased apoptosis. In the absence of p53, the developmental defects associated with Bard1 deficiency are partly ameliorated, and the lethality of Bard1; p53-nullizygous mice is delayed until E9.5. This result, together with the increased chromosomal aneuploidy of Bard1 mutant cells, indicates a role for Bard1 in maintaining genomic stability. The striking similarities between the phenotypes of Bard1-null, Brca1-null, and double Bard1; Brca1-null mice provide strong genetic evidence that the developmental functions of Brca1 and Bard1 are mediated by the Brca1/Bard1 heterodimer.
* Corresponding author. Mailing address: Department of Anatomy & Cell Biology and Institute of Cancer Genetics, Russ Berrie Medical Science Pavilion, Room 607A, Columbia University, 1150 St. Nicholas Ave., New York, NY 10032. Phone: (212) 851-5234. Fax: (212) 851-5236. E-mail: TL54{at}columbia.edu.
Molecular and Cellular Biology, July 2003, p. 5056-5063, Vol. 23, No. 14
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.14.5056-5063.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Shakya, R., Szabolcs, M., McCarthy, E., Ospina, E., Basso, K., Nandula, S., Murty, V., Baer, R., Ludwig, T.
(2008). The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl. Acad. Sci. USA
105: 7040-7045
[Abstract]
[Full Text]
-
Li, L., Ryser, S., Dizin, E., Pils, D., Krainer, M., Jefford, C. E., Bertoni, F., Zeillinger, R., Irminger-Finger, I.
(2007). Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers. Cancer Res.
67: 11876-11885
[Abstract]
[Full Text]
-
Laufer, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., Baer, R.
(2007). Structural Requirements for the BARD1 Tumor Suppressor in Chromosomal Stability and Homology-directed DNA Repair. J. Biol. Chem.
282: 34325-34333
[Abstract]
[Full Text]
-
Tembe, V., Henderson, B. R.
(2007). BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis. J. Biol. Chem.
282: 20513-20522
[Abstract]
[Full Text]
-
Yeh, J.-R. J., Ju, R., Brdlik, C. M., Zhang, W., Zhang, Y., Matyskiela, M. E., Shotwell, J. D., Crews, C. M.
(2006). Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc. Natl. Acad. Sci. USA
103: 10379-10384
[Abstract]
[Full Text]
-
Simons, A. M., Horwitz, A. A., Starita, L. M., Griffin, K., Williams, R. S., Glover, J.N. M., Parvin, J. D.
(2006). BRCA1 DNA-Binding Activity Is Stimulated by BARD1. Cancer Res.
66: 2012-2018
[Abstract]
[Full Text]
-
Choudhury, A. D., Xu, H., Modi, A. P., Zhang, W., Ludwig, T., Baer, R.
(2005). Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells. J. Biol. Chem.
280: 24669-24679
[Abstract]
[Full Text]
-
Schuchner, S., Tembe, V., Rodriguez, J. A., Henderson, B. R.
(2005). Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1. J. Biol. Chem.
280: 8855-8861
[Abstract]
[Full Text]
-
Karppinen, S-M, Heikkinen, K, Rapakko, K, Winqvist, R
(2004). Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J. Med. Genet.
41: e114-e114
[Full Text]
-
Choudhury, A. D., Xu, H., Baer, R.
(2004). Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression. J. Biol. Chem.
279: 33909-33918
[Abstract]
[Full Text]
-
Morris, J. R., Solomon, E.
(2004). BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum Mol Genet
13: 807-817
[Abstract]
[Full Text]
-
Westermark, U. K., Reyngold, M., Olshen, A. B., Baer, R., Jasin, M., Moynahan, M. E.
(2003). BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks. Mol. Cell. Biol.
23: 7926-7936
[Abstract]
[Full Text]
-
Wu-Baer, F., Lagrazon, K., Yuan, W., Baer, R.
(2003). The BRCA1/BARD1 Heterodimer Assembles Polyubiquitin Chains through an Unconventional Linkage Involving Lysine Residue K6 of Ubiquitin. J. Biol. Chem.
278: 34743-34746
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.